Disparate responses of tumour vessels to angiotensin II: Tumour volume-dependent effects on perfusion and oxygenation

British Journal of Cancer

Volumn 83, Issue 2, 2000, Pages 225-231

  Thews, O ^a   Kelleher, D K ^a   Vaupel, P ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Angiotensin II; Tumour blood flow; Tumour oxygenation; Tumour perfusion; Tumour vasculature

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CATHETER; DOPPLER FLOWMETRY; ELECTRODE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; OXYGEN TENSION; POLAROGRAPHY; PRIORITY JOURNAL; RAT; TUMOR BLOOD FLOW; TUMOR VASCULARIZATION; TUMOR VOLUME; VASOCONSTRICTION;

EID: 0034125262     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2000.1229     Document Type: Article

References (63)

1. Andrade SP and Beraldo WT (1998) Pharmacological reactivity of neoplastic and non-neoplastic associated neovasculature to vasoconstrictors. Int J Exp Pathol 79: 425-432
2. Braun RD, Lanzen JL and Dewhirst MW (1999) Fourier analysis of fluctuations of oxygen tension and blood flow in R3230Ac tumors and muscle in rats. Am J Physiol 277: H551-H568
3. Brizel DM, Scully SP, Harrelson JM, Layfield LJ, Bean JM, Prosnitz LR and Dewhirst MW (1996) Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res 56: 941-943
4. Bush RS, Jenkin RDT, Allt WEC, Beale FA, Dembo AJ and Pringle JF (1978) Definitive evidence for hypoxic cells influencing cure in cancer therapy. Br J Cancer 37 (Suppl. 3): 302-306
5. Cater DB, Grigson CMB and Watkinson DA (1962) Changes of oxygen tension in tumours induced by vasoconstrictor and vasodilator drugs. Acta Radiol 58: 401-436
6. Chaplin DJ and Hill SA (1995) Temporal heterogeneity in microregional erythrocyte flux in experimental solid tumours. Br J Cancer 71: 1210-1213
7. Day ED (1964) Vascular relationships of tumor and host. Prog Exp Tumor Res 4: 57-97
8. 2 of R3230AC tumors in Fischer 344 rats. Int J Radiat Oncol Biol Phys 42: 723-726
9. Dworkin MJ, Carnochan P and Allen-Mersh TG (1995) Nitric oxide inhihition sustains vasopressin-induced vasoconstriction. Br J Cancer 71: 942-944
10. Dworkin MJ, Carnochan P and Allen-Mersh TG (1997) Effect of continuous regional vasoactive agent infusion on liver metastasis blood flow. Br J Cancer 76: 1205-1210
11. Freitas I and Baronzio GF (1991) Tumor hypoxia, reoxygenation and oxygenation strategies: Possible role in photodynamic therapy. J Photochem Photobiol 11: 3-30
12. Giaccia AJ (1996) Hypoxic stress proteins: survival of the fittest. Seminars in Radiation Oncology 6: 46-58
13. Graeber TG, Osmanian C, Jacks T, Housman DE, Koch CJ, Lowe SW and Giaccia AJ (1996) Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 379: 88-91
14. Gulledge CJ and Dewhirst MW (1996) Tumor oxygenation: A matter of supply and demand. Anticancer Res 16: 741-750
15. Gullino PM and Grantham FH (1961) Studies on the exchange of fluids between host and tumor. II. The blood flow of hepatomas and other tumors in rats and mice. J Natl Cancer Inst 27: 1465-1491
16. Hall EJ (1994) Radiobiology for the Radiologist. Lippincott: Philadelphia
17. Hemingway DM, Angerson WJ, Anderson JH. Goldberg JA, McArdle CS and Cooke TG (1992) Monitoring blood flow to colorectal liver metastases using laser Doppler flowmetry: the effect of angiotensin II. Br J Cancer 66: 958-960
18. Hirst DG (1989) Tumor blood flow modification therapeutic benefit: is this approach ready for clinical application? Review. In Gray Laboratory 1989 Annual Report, Michael B, Hance M (eds) pp 14-17. Cancer Research Campaign: London
19. Hirst DG, Hirst VK, Shaffi KM, Prise VE and Joiner B (1991) The influence of vasoactive agents on the perfusion of tumours growing in three sites in the mouse. Int J Radiat Biol 60: 211-218
20. 2 predicts survival in advanced cancer of the uterine cervix. Radiother Oncol 26: 45-50
21. Höckel M, Schlenger K, Aral B, Mitze M, Schäffer U and Vaupel P (1996) Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 56: 4509-4515
22. Hori K, Suzuki M, Abe I, Saito S and Sato H (1985) Increase in tumor vascular area due to increased blood flow by angiotensin II in rats. J Natl Cancer Inst 74: 453-459
23. Hori K, Zhang QH, Saito S, Tanda S, Li HC and Suzuki M (1993) Microvascular mechanisms of change in tumor blood flow due to angiotensin II, epinephrine, and methoxamine: a functional morphometric study. Cancer Res 53: 5528-5534
24. Horsman MR (1993) Hypoxia in tumours: its relevance, identification, and modification. In Medical Radiology. Current topics in clinical radiobiology Beck-Bomholdt HP (ed) pp. 99-112. Springer: Berlin
25. Jain RK and Ward-Hartley (1984) Tumor blood flow - characterization, modifications, and role of hyperthermia. IEEE Trans Son Ultrason SU-31: 504-526
26. Jirtle RL (1988) Chemical modification of tumour blood flow. Int J Hyperthermia 4: 355-371
27. Jirtle R, Clifton KH and Rankin JH (1978) Effects of several vasoactive drugs on the vascular resistance of MT-W9B tumors in W/Fu rats. Cancer Res 38: 2385-2390
28. Kelleher DK, Engel T and Vaupel PW (1995) Changes in microregional perfusion, oxygenation, ATP and lactate distribution in subcutaneous rat tumours upon water-filtered IR-A hyperthermia. Int J Hyperthermia 11: 241-255
29. Kelleher DK, Thews O and Vaupel P (1998) Regional perfusion and oxygenation of tumors upon methylxanthine derivative administration. Int J Radiat Oncol Biol Phys 42: 861-864
30. Kennovin GD, Flitney FW and Hirst DG (1994) 'Upstream' modification of vasoconstrictor responses in rat epigastric artery supplying an implanted tumour. Adv Exp Med Biol 345; 411-416
31. Kimura H, Braun RD, Ong ET, Hsu R, Secomb TW, Papahadjopoulos D, Hong K and Dewhirst-MW (1996) Fluctuations in red cell flux in tumor microvessels can lead to transient hypoxia and reoxygenation in tumor parenchy ma. Cancer Res 56: 5522-5528
32. Kohzuki M, Tanda S, Hori K, Yoshida K, Kamimoto M, Wu XM and Sato T (1998) Endothelin receptors and angiotensin II receptors in tumor tissue. J Cardiovasc Pharmacol 31 (Suppl. 1): S531-S533
33. Konerding MA, Steinberg F and Budach V (1989a) The vascular system of xenotransplanted tumors - scanning electron and light microscopic studies. Scanning Microsc 3: 327-335
34. Konerding MA, Steinberg F and Streffer C (1989b) The vasculature of xenotransplanted human melanomas and sarcomas on nude mice. I. Vascular corrosion casting studies. Acta Anat (Basel) 136: 21-26
35. Konerding MA, Steinberg F and Streffer C (1989c) The vasculature of xenotransplanted human melanomas and sarcomas on nude mice. II. Scanning and transmission electron microscopic studies. Acta Anat (Basel) 136: 27-33
36. Konerding MA, Miodonski AJ and Lametschwandtner A (1995) Microvascular corrosion casting in the study of tumor vascularity: a review. Scanning Microsc 9: 1233-1243
37. Mattsson J, Alpsten M, Appelgren L and Peterson HI (1980) Influence of noradrenaline on local tumor blood flow. Eur J Cancer 16: 99-102
38. Mattsson J, Appelgren L, Hamberger B and Peterson HI (1979) Tumor vessel innervation and influence of vasoactive drugs on tumor blood flow. In Tumor Blood Circulation Peterson HI (ed) pp 129-135. CRC Press: Boca Raton
39. Netti PA, Hamberg LM, Babich JW, Kierstead D, Graham W, Hunter GJ, Wolf GL, Fischman A, Boucher Y and Jain RK (1999) Enhancement of fluid filtration across tumor vessels: implication for delivery of macromolecules. Proc Natl Acad Sci USA 96: 3137-3142
40. Nordsmark M, Overgaard M and Overgaard J (1996) Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother Oncol 41: 31-39
41. Peterson HI (1983) Innervation von Tumorgefässen, Einfluss vasoaktiver Substanzen und Regulation der Tumordurchblutung. Mikrozirk Forsch Klin 2: 69-77
42. Peterson HI (1991) Modification of tumour blood flow - a review. Int J Radiat Biol 60: 201-210
43. Powell ME, Hill SA, Saunders MI, Hoskin PJ and Chaplin DJ (1997) Human tumor blood flow is enhanced by nicotinamide and carbogen breathing. Cancer Res 57: 5261-5264
44. Reinhold HS (1979) In vivo observations of tumor blood flow. In Tumor Blood Circulation Peterson HI (ed) pp 115-128. CRC Press: Boca Raton
45. Shan SQ, Rosner GL, Braun RD, Hahn J, Pearce C and Dewhirst MW (1997) Effects of diethylamine/nitric oxide on blood perfusion and oxygenation in the R3230Ac mammary carcinoma. Br J Cancer 76: 429-437
46. Shankar A, Loizidou M, Bumstock G and Taylor I (1999) Noradrenaline improves the tumour to normal blood flow ratio and drug delivery in a model of liver metastases. Br J Surg 86: 453-457
47. Suzuki M, Hori K, Abe I, Saito S and Sato H (1981) A new approach to cancer chemotherapy: selective enhancement of tumor blood flow with angiotensin II. J Natl Cancer Inst 67: 663-669
48. Suzuki M, Hori K, Abe I, Saito S and Sato H (1982) Selective increase in tumor oxygen tension with angiotensin II. Invasion Metastasis 2: 33-39
49. Suzuki M, Hori K, Abe I, Saito S and Sato H (1984) Functional characterization of the microcirculation in tumors. Cancer Metastasis Rev 3: 115-126
50. Tokuda K, Abe H, Aida T, Sugimoto S and Kaneko S (1990) Modification of tumor blood flow and enhancement of therapeutic effect of ACNU on experimental rat gliomas with angiotensin II. J Neurooncol 8: 205-212
51. Tozer GM and Shaffi KM (1993) Modification of tumour blood flow using the hypertensive agent angiotensin II. Br J Cancer 67: 981-988
52. Tozer GM and Shaffi KM (1995) The response of tumour vasculature to angiotensin II revealed by its systemic and local administration to "tissue-isolated" tumours. Br J Cancer 72: 595-600
53. Tozer GM, Shaffi KM, Prise VE and Bell KM (1996) Spatial heterogeneity of tumour blood flow modification induced by angiotensin II: Relationship to receptor distribution. Int J Cancer 65: 658-663
54. Trotter MJ, Chaplin DJ and Olive PL (1991) Effect of angiotensin II on intermittent tumour blood flow and acute hypoxia in the murine SCCVII carcinoma. Eur J Cancer 27: 887-893
55. UKCCCR (1998) United Kingdom Co-ordinating Committee on Cancer Research guidelines for the welfare of animals in experimental neoplasia (2nd edn). Br J Cancer 77: 1-10
56. Vaupel PW (1993) Oxygenation of solid tumors. In Drug Resistance in Oncology Teicher BA (ed) pp 53-85. Marcel Dekker: New York
57. Vaupel P, Kelleher DK, Thews O and Hummel M (2000) Tumour blood flow: critical issues and modification. In: Moriarty M, Mothersill C, Seymour C, Edington M, Ward JF, Fry RJM (eds) Radiation Research, Vol. 2 (Proceedings, 11th International Congress on Radiation Research). Allen Press, Lawrence
58. Vaupel P and Gabbert H (1986) Evidence for and against a tumor type-specific vascularity. Strahlenther Onkol 162: 633-638
59. Vaupel P and Mueller-Klieser W (1986) Cell line and growth site as relevant parameters governing tumor tissue oxygenation. Adv Exp Med Biol 200: 633-643
60. Vaupel P, Kallinowski F and Okunieff P (1989) Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 49: 6449-6465
61. Vaupel P, Kelleher DK and Thews O (1998) Modulation of tumor oxygenation. Int J Radiat Oncol Biol Phys 42: 843-848
62. 2 tension measurements. Cancer Res 51: 3316-3322
63. Warren BA (1979) The vascular morphology of tumors. In Tumor Blood Circulation, Peterson HT (ed) pp 1-47 CRC Press: Boca Raton